High-efficiency CRISPR/Cas12Ultra gene editing tool with independent patent protection for gene therapy applications including CAR-T cell therapy. Advanced molecular diagnostic and therapeutic tool.
Manufactured by
China
Guangzhou Magigen Biotechnology manufactures molecular biology enzymes and reagents for IVD diagnostics and life sciences research, including CRISPR Cas proteins (Cas9, Cas12a, Cas13a), reverse transcriptases, Taq polymerase, LAMP isothermal amplification kits, and RNase inhibitors. The company also offers IVD CDMO production services for molecular diagnostic product development. No certification information was provided on the website.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
GeneCker Co., Ltd.
South Korea · 8 relevant products
Apto-Gen Ltd
United Kingdom · 1 relevant product
Intelligenome
United States · 2 relevant products
Beijing SynsorBio Technology Co., Ltd
China · 3 relevant products
Nagase Diagnostics Co., Ltd.
Japan · 1 relevant product
Genesystem Co., Ltd.
South Korea · 1 relevant product
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 1 relevant product
Genetic Tools, LLC
United States · 1 relevant product
Eone-Diagnomics Genome Center
South Korea · 1 relevant product
Bioscience (Tianjin) DiagnosticTechnology Co.,Ltd
China · 1 relevant product
23 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →3 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 49 closest product alternatives
GeneCker Co., Ltd. · South Korea
A diagnostic product utilizing GeneCker's ultra-precision CRISPR/Cas9 technology for genetic analysis. Part of GeneCker's one-stop cancer diagnosis platform that includes sample collection, DNA sequencing, and data output capabilities.
GeneCker Co., Ltd. · South Korea
A diagnostic product utilizing GeneCker's ultra-precision CRISPR/Cas9 technology for genetic analysis. Part of GeneCker's one-stop cancer diagnosis platform that includes sample collection, DNA sequencing, and data output capabilities.
Apto-Gen Ltd · United Kingdom
Optimized enzyme components for nucleic acid amplification and detection in molecular diagnostics. Provides consistent performance in various assay formulations and detection platforms.
GeneCker Co., Ltd. · South Korea
A diagnostic product utilizing GeneCker's ultra-precision CRISPR/Cas9 technology for genetic analysis. Part of GeneCker's one-stop cancer diagnosis platform that includes sample collection, DNA sequencing, and data output capabilities.
GeneCker Co., Ltd. · South Korea
A diagnostic product utilizing GeneCker's ultra-precision CRISPR/Cas9 technology for genetic analysis. Part of GeneCker's one-stop cancer diagnosis platform that includes sample collection, DNA sequencing, and data output capabilities.
Intelligenome · United States
CRISPR-based diagnostic assay for oncology applications. Provides molecular detection and monitoring capabilities for cancer-related diagnostics.
Beijing SynsorBio Technology Co., Ltd · China
CRISPR-based molecular diagnostic test for tumor detection utilizing proprietary isothermal amplification and microfluidic integration. Enables rapid point-of-care testing with high sensitivity and specificity for oncology screening and monitoring applications.
GeneCker Co., Ltd. · South Korea
Molecular diagnostic test using CRISPR/Cas9 technology to identify and amplify mutant DNA sequences in patient samples. Provides standardized detection and quantification of cancer-related genetic mutations.
Beijing SynsorBio Technology Co., Ltd · China
Single-target CRISPR detection device for point-of-care testing applications. Integrates CRISPR-based molecular detection with microfluidics technology to enable rapid, accurate identification of specific nucleic acid targets in clinical specimens. Designed for decentralized diagnostic workflows requiring minimal infrastructure.
GeneCker Co., Ltd. · South Korea
A cancer diagnosis platform product utilizing GeneCker's ultra-precision CRISPR/Cas9 technology for standardization of liquid biopsy diagnosis. Integrates sample collection, DNA sequencing via NGS or Sanger sequencing methods, and provides results in result booklet or PDF format.
Nagase Diagnostics Co., Ltd. · Japan
Genetically engineered enzymes produced using proprietary recombination technology for diagnostic applications. These products offer improved specificity and stability for various clinical assays.
Genesystem Co., Ltd. · South Korea
Advanced reagent technology enabling ultra-fast PCR test performance with Genesystem molecular diagnostics platforms.
37 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products